Chemours Co
NYSE:CC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.79
32.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Chemours Co
Wall Street
Price Targets
CC Price Targets Summary
Chemours Co
According to Wall Street analysts, the average 1-year price target for
CC
is 26.41 USD
with a low forecast of 21.21 USD and a high forecast of 36.75 USD.
CC Last Price Targets
Chemours Co
The latest public price target was made on Oct 11, 2024 by
Arun Viswanathan
from
RBC Capital
,
who expects
CC
stock to
rise by 65%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Arun Viswanathan
RBC Capital
|
28
USD
Upside 65% |
2 months ago
Oct 11, 2024
|
Chemours price target lowered to $28 from $35 at RBC Capital
TheFly
|
John McNulty
BMO Capital
|
32
USD
Upside 88% |
2 months ago
Oct 7, 2024
|
Chemours price target raised to $32 from $30 at BMO Capital
TheFly
|
|
John McNulty
BMO Capital
|
30
USD
Upside 76% |
4 months ago
Aug 6, 2024
|
Chemours (CC) PT Lowered to $30 at BMO Capital
StreetInsider
|
John Roberts
Mizuho Securities
|
25
USD
Upside 47% |
6 months ago
Jun 7, 2024
|
Chemours initiated with a Neutral at Mizuho
TheFly
|
Rich Hilliker
UBS
|
31
USD
Upside 82% |
7 months ago
May 29, 2024
|
Box, Inc. (BOX) PT Lowered to $31 at UBS
StreetInsider
|
|
John McNulty
BMO Capital
|
34
USD
Upside 100% |
8 months ago
Apr 9, 2024
|
BMO Capital Upgrades Chemours (CC) to Outperform
StreetInsider
|
|
Joshua Spector
UBS
|
28
USD
Upside 65% |
8 months ago
Apr 1, 2024
|
Chemours price target raised to $28 from $21 at UBS
TheFly
|
Emily Nassedd Mitsch
CFRA
|
18
USD
Upside 6% |
8 months ago
Apr 1, 2024
|
Chemours (CC) PT Raised to $18 at CFRA
StreetInsider
|
Linda Bolton Weiser
D.A. Davidson
|
24
USD
Upside 41% |
9 months ago
Mar 13, 2024
|
Nature's Sunshine Products (NATR) PT Raised to $24 at DA Davidson
StreetInsider
|
|
Arun Viswanathan
RBC Capital
|
40
USD
Upside 135% |
1 year ago
Dec 1, 2023
|
Analyst Boosts This Manufacturer Stock To Outperform, Ups Price Target By Over 40%
Benzinga
|
Vincent Andrews
Morgan Stanley
|
33
USD
Upside 94% |
1 year ago
Oct 30, 2023
|
Check Out 3 Materials Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CC's stock price target?
Price Target
26.41
USD
According to Wall Street analysts, the average 1-year price target for
CC
is 26.41 USD
with a low forecast of 21.21 USD and a high forecast of 36.75 USD.
What is Chemours Co's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Chemours Co's revenue is
1%.
The projected
CAGR
for the next 3 years is
3%.
You don't have any saved screeners yet
